Loading fund overlap…
7 of 200 unique stocks in common · Jaccard: 3.5%
A weighted portfolio overlap of 5.11% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹5.11 is allocated to the exact same companies at the same relative proportions. The schemes share 7 common holdings.
The largest overlapping asset in their portfolios is Sun Pharmaceutical Industries, which commands a weight of 13.91% in Back to Index and 2.65% in ICICI Prudential Large Cap Fund. Holding both schemes increases your concentration in Sun Pharmaceutical Industries rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Back | in ICICI |
|---|---|---|
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 13.91% | 2.65% |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | 5.74% | 0.87% |
| Max Healthcare InstituteHealthcare Services | 5.23% | 0.59% |
| Zydus LifesciencesPharmaceuticals & Biotechnology | 1.60% | 0.40% |
| CiplaPharmaceuticals & Biotechnology | 5.28% | 0.33% |
| LupinPharmaceuticals & Biotechnology | 3.97% | 0.19% |
| Apollo Hospitals EnterpriseHealthcare Services | 5.55% | 0.08% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.